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RESEARCH NOTE
A pilot observational study measuring 
acute sarcopenia in older colorectal surgery 
patients
Carly Welch1,2* , Carolyn A. Greig3,4,5, Zaki K. Hassan‑Smith2,6, Thomas D. Pinkney7, Janet M. Lord1,4,5 
and Thomas A. Jackson1,2
Abstract 
Objective: To explore variability in acute changes in muscle mass and function in older patients undergoing elective 
colorectal surgery, as well as feasibility of measures, in order to refine study processes to inform the protocol for a 
larger study.
Results: Results are presented for seven participants recruited to this pilot study. It is possible to perform serial 
measurements of bilateral anterior thigh thickness (BATT) and handgrip strength prior to, within 24 h of surgery, 
and 1 week postoperatively. Gait speed can be reliably measured preoperatively and at 1 week postoperatively. In 
this pilot study, BATT and gait speed declined at 1 week postoperatively (median BATT 4.17 cm, 3.47 cm, p = 0.028; 
median gait speed 0.89 m/s, 0.83 m/s, p = 0.043). Baseline hsCRP correlated with change in BATT (τb = 0.73, p = 0.04) 
and baseline DHEA‑S correlated with change in gait speed (τb = 0.87, p = 0.02). This pilot study has assisted to refine 
the protocol for our larger study, which will further characterise these changes.
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Introduction
Sarcopenia is defined as reduced muscle mass and func-
tion [1]. European Working Group on Sarcopenia in 
Older People 2 (EWGSOP2) distinguishes acute from 
chronic sarcopenia [2]. Acute sarcopenia develops within 
6  months, normally triggered by a stressor event [2]. 
Hospitalisation is associated with bedrest and inflamma-
tory response, which can drive catabolism/reduce anabo-
lism, inducing reductions in muscle mass and function; 
this is exacerbated by age [3, 4]. Precise mechanisms 
remain unclear. Overview of acute sarcopenia including 
proposed mechanisms and effectors has been published 
elsewhere [5].
Colorectal surgery is commonly performed on older 
adults for localised cancer resection [6, 7] and trig-
gers acute inflammatory response [8]. Patients do not 
normally experience preoperative functional decline or 
cachexia [9]. Characterising acute sarcopenia in these 
patients will help to increase understanding, identify 
mechanistic pathways, and target interventions, with 
potential to improve postoperative recovery and longer-
term physical function. This study aimed to refine the 
protocol for a larger study by exploring feasibility and 
variability of measures.
Main text
Methods
Study design
Participants were recruited from Queen Elizabeth Hos-
pital Birmingham preoperative assessment clinic during 
August–October 2017. We included people aged 65 and 
older, planned to undergo major colorectal surgery (any 
indication), and able to give informed consent. Exclusion 
criteria were life expectancy 30 days or less and inability 
to understand verbal English. Known muscular disor-
ders were not an exclusion criterion. Measurements were 
taken prior to admission (Visit 1), within 24 h of surgery 
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(Visit 2), and 1 week postoperatively or day of discharge 
(Visit 3). A single geriatrician with training in procedures 
performed all assessments (CW). All assessments not 
possible to perform and reasons for this were recorded.
Muscle mass measurement
Quadriceps muscle thickness was measured using 
B-mode ultrasonography (Venue 50, GE Healthcare, UK). 
Participants were positioned semi-upright, with a firm 
wedge below the knees, and advised to relax their mus-
cles. Measurements were taken in transverse plane at 
mid-point between greater trochanter and knee joint line. 
Thickness of subcutaneous tissue (SC), rectus femoris 
(RF), and vastus intermedius (VI), excluding fascia, were 
measured. Three measurements were taken on each side 
at each visit and means calculated; a fourth was taken 
if measurements differed more than 10%. Total bilat-
eral anterior thigh thickness (BATT) (right RF + right 
VI + left RF + left VI), and BATT:SC ratio (BATT-SCR) 
were calculated. This method has excellent intra-rater 
and inter-rater reliability and mean BATT correlates with 
bioelectrical impedance analysis (BIA) in healthy young 
adults [10].
Muscle strength measurement
Handgrip strength was measured at each visit using a 
Jamar hydraulic handheld dynamometer (Patterson Med-
ical, Warrenville, IL, USA). Participants were positioned 
with elbows flexed at 90°, forearms in neutral position 
and advised to “squeeze as hard as [they] can”. Highest 
recording of two measurements on each side was used 
for analysis [11].
Physical performance testing
Short Physical Performance Battery (SPPB) was scored 
at Visit 1; incorporates gait speed, side-by-side/tandem 
stand, and five chair stands [12]. We initially planned to 
measure SPPB at all visits; upon consideration of effect 
of intra-abdominal strain limiting chair stands, gait speed 
alone was measured at Visit 3. Gait speed is a widely 
accepted measure of physical performance [1, 13]. A 4 m 
course was used.
Comprehensive geriatric assessment
During Visit 1, comprehensive geriatric assessment 
(CGA) was performed by a single geriatrician (CW). 
This included Mini-Nutritional Assessment Short Form 
(MNA-SF) [14], Addenbrooke’s Cognitive Examina-
tion-III (ACE-III) [15], evaluation of basic [16, 17] and 
instrumental activities of daily living (ADLs) [18], Geri-
atric Depression Scale Five-Point (GDS-5) [19, 20], and 
questioning on falls and admissions within the last year. 
Comorbidities and symptomatic burden were used to 
calculate the Geriatric Index of Comorbidity (GI-C) [21]. 
Frailty was defined by Fried frailty phenotype [22, 23] and 
Clinical Frailty Scale [24]. Delirium screening with 4AT 
was performed at each visit [25]. Variables measured 
were considered potential effectors of acute sarcopenia 
[5]. These were included to assess feasibility and accept-
ability of measurement, and document individual differ-
ences (Fig. 1).
Sarcopenia definition
This study was completed prior to EWGSOP2 dissemi-
nation; sarcopenia was defined using initial EWGSOP 
definition by low BATT (muscle mass) and either low 
handgrip strength or gait speed [1]. Cut-off values were 
taken two SDs below young healthy reference popula-
tion means. Cut-off values were 3.86  cm (women) and 
5.44 cm (men) for BATT [10], 20 kg (women) and 30 kg 
(men) for handgrip strength [13], and 0.8 m/s (both gen-
ders) for gait speed [13]. Low BATT alone was defined as 
pre sarcopenia; severe sarcopenia was defined as all three 
criteria below cut-offs [1].
Enzyme‑linked immunosorbent assays (ELISAs)
Blood samples were taken at Visit 1 with serum prepared 
within 30–60  min of collection and stored at − 80  °C. 
Cortisol, dehydroepiandrosterone sulfate (DHEA-S), and 
high sensitivity C-Reactive Protein (hsCRP) (IBL Inter-
national; Hamburg, Germany), and vitamin D (Immun-
diagnostik AG 25(OH)-vitamin D direct day ELISA; 
Bensheim, Germany) were measured by ELISA using 
commercial kits. Optical density was measured immedi-
ately using a photometer at 450 nm (Sci-Tek Instuments 
Ltd Synergy HT).
Data management and analysis
Data were entered into Microsoft Excel 2010, converted 
to IBM SPSS Statistics 22, and visually assessed for nor-
mality. Significance of differences between serial BATT, 
BATT-SCR, echogenicity, and handgrip strength were 
calculated using Friedman and post hoc Wilcoxon signed 
rank tests. Significance of difference in gait speed was 
calculated using Wilcoxon signed rank testing. Correla-
tion between baseline immune-endocrine markers and 
changes in BATT, handgrip strength, and gait speed were 
assessed using Kendall’s correlation. Difference in pre sar-
copenia, sarcopenia, and severe sarcopenia rates between 
Visit 1 and Visit 3 were analysed using Chi squared test. 
Measurements not obtained at any visit were analysed as 
missing values.
Ethical considerations
Ethical approval was obtained from Wales REC 6 (17/
WA/0117). Written informed consent was obtained from 
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participants. Specific optional consent was obtained to 
consent to remain included in the event they lost capacity 
to consent during the study. If this were to occur, sepa-
rate consultee declaration was planned to be obtained 
from nominated consultees.
Results
17 patients were approached to participate in this 
study; eight were recruited. One participant withdrew 
following Visit 1; data were not analysed. One partici-
pant declined handgrip strength testing at Visit 2, and 
one participant declined Visit 3 assessment. Visit 3 
was conducted on median day 7 (IQR 5–8). Additional 
file  1 shows recruitment and follow-up flowchart for 
this study. Table  1 displays summary statistics. Mean 
age was 74.7  years (SD 4.1). 85.7% participants were 
male. All were White British ethnicity. All participants 
included in analysis underwent operations for cancer or 
suspected cancer (e.g. suspicious polyp) (Table 1).
Changes in muscle mass and function
BATT and BATT-SCR differed between visits 
(p = 0.006; p = 0.006). Median BATT was 4.17 cm (IQR 
3.88–4.39) at Visit 1, 5.01  cm (IQR 3.89–5.47) at Visit 
2 (p = 0.028 Visit 1), and 3.47  cm (IQR 3.21–3.81) at 
Visit 3 (p = 0.028 Visit 1; p = 0.028 Visit 2). Median 
BATT-SCR was 8.78 (IQR 6.67–13.08) at Visit 1, 5.03 
(IQR 4.72–5.32) at Visit 2 (p = 0.018 Visit 1), and 3.94 
(IQR 2.82–5.01) at Visit 3 (p = 0.028 Visit 1; p = 0.046 
Visit 2). There was no significant change in handgrip 
strength (p = 0.692). Gait speed declined from median 
0.89 m/s (IQR 0.78–1.06) at Visit 1 to median 0.83 m/s 
(IQR 0.68–0.91) at Visit 3 (p = 0.043).  Results are 
shown in Fig. 1a–c.
Acute sarcopenia
Prevalence of sarcopenia at baseline was 28.6%. As 
assessments were not performed on one participant at 
Visit 3, incidence of acute sarcopenia at Visit 3 was 75%. 
Overall prevalence of sarcopenia at Visit 3 was 83.3%. 
One participant, who had pre sarcopenia at Visit 1, devel-
oped severe sarcopenia. Changes were not statistically 
significant (p = 0.558). Results are shown in Fig. 1d. 
Immune‑endocrine markers
There was a positive association between base-
line DHEA-S and gait speed change (τb = 0.87, 
p = 0.02)  (Fig.  2a), and between baseline hsCRP and 
BATT change τb = 0.73, p = 0.04)  (Fig.  2b). No other 
significant associations were identified.
Feasibility and acceptability of measurements
It was possible to perform all muscle assessments in all 
participants at Visit 1. BATT was measured at each visit 
with participants, although one participant declined all 
assessments at Visit 3. One participant declined hand-
grip strength assessment at Visit 2. SPPB was measured 
at baseline; only gait speed was measured at Visit 3, due 
to potential harm from abdominal strain in perform-
ing chair stands. Nutritional, mood, functional, and 
Table 1 Demographics and basic participant information
The mean age of participants was 74.7 years, with 85.7% being of a male gender. 
100% of participants were White British. 85.7% of participants were not frail 
at baseline by CFS and Fried criteria. Operations performed included ileocecal 
resection, right hemicolectomy, anterior resection, and abdominoperineal 
resection. 85.7% were performed as open procedures
Mean SD
Age (years) 74.7 4.1
BMI (kg/m2) 24.9 1.8
Median IQR
Medications (N) 6 1–6
Falls over last year (N) 0 0–1
Admissions over last year (N) 0 0
Length of stay (days) 7 5–10
N Percent of study sample
Male gender 6 85.7
Ethnicity (White British) 7 100
GI‑C
 1 1 14.3
 2 4 57.1
 3 2 28.6
 4 0 0
GDS ≥ 2 1 14.3
MNA‑SF
 Malnourished 0 0
 At risk 2 28.6
 Not malnourished 5 71.4
CFS (baseline)
 1–3 6 85.7
 4–5 1 14.3
 6–8 0 0
Frailty–Fried (baseline)
 Not frail 6 85.7
 Pre‑frail 1 14.3
 Frail 0 0
Surgical technique (open) 6 85.7
Operation
 Ileocecal resection 1 14.3
 Right hemicolectomy 4 57.1
 Anterior resection 1 14.3
 Abdominoperineal resection 1 14.3
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comorbidity assessment were performed in all partici-
pants at Visit 1. Cognitive screening was initially per-
formed, but following withdrawal of one participant due 
to burden of assessment, a decision was made to remove 
formal cognitive testing. Participants expressed they 
found all other assessments acceptable. No participant 
exhibited loss of capacity, but all participants consented 
to ongoing inclusion in the event they should have lost 
capacity during the study.
Discussion
Prevalence of sarcopenia at Visit 1 was similar to previ-
ous studies in hospitalised older patients [26–29]. Reduc-
tion in BATT and gait speed, and increased prevalence 
of sarcopenia at Visit 3 compared to Visit 1 was demon-
strated. Muscle strength change showed greater variabil-
ity between participants. The next stage of our research 
will characterise a larger cohort, including elective and 
emergency admissions, and include three-month follow-
up. We have shown that measurement of these variables 
is feasible in an acute care setting. Due to perceived bur-
den of ACE-III, and following further public involve-
ment, this will not be measured in our main study. This 
should enable time to focus on nutritional  and physi-
cal  function assessment, and comparison measurements 
of muscle mass with BIA.
BATT increased at Visit 2 in all but one participant; 
BATT-SCR reduced across visits for all participants. 
This suggests increased BATT was associated with 
increased SC thickness. We consider increased SC thick-
ness more likely represents oedema than increase in fat 
tissue. Similar findings have been demonstrated in criti-
cal care patients following cardiothoracic surgery, with 
quadriceps muscle thickness correlating with fluid bal-
ance [30]. However, changes in fluid balance alone may 
Fig. 1 Change in muscle mass and function measured during this pilot study. BATT increased within 24 h of surgery and declined at visit 3 (a). 
Handgrip strength varied widely; two participants experienced increases in handgrip strength and the rest experienced decreases (b). Gait speed 
declined from visit 1 to visit 3 (c). Although not statistically significant in this pilot, there was a higher prevalence of sarcopenia at visit 3 compared 
to visit 1 (d). Cut‑off points are indicated [BATT 3.86 cm (women), 5.44 cm (men); muscle strength 20 kg (women), 30 kg (men); gait speed 0.8 m/s 
(both genders)]
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be insufficient to explain this. Fluid shifts may have been 
exacerbated by systemic inflammation and increased 
vascular permeability postoperatively [31]. Consider-
ing increases in BATT within 24  h of surgery may rep-
resent heightened systemic inflammation, this should not 
be disregarded as a benign process. If acute increase in 
BATT relates to increased inflammation, this could her-
ald increased likelihood of developing acute sarcopenia. 
Our planned larger study will assess if rate of change to 
Visit 2 predicts rate of change to Visit 3.
Baseline hsCRP correlated with change in BATT 
to Visit 3, suggesting older adults with lower baseline 
inflammation were at greater risk of acute reductions 
in muscle size. This is converse to associations demon-
strated in chronic sarcopenia; higher levels of hsCRP 
and proinflammatory cytokines have been demonstrated 
in older adults with sarcopenia [32] although, a positive 
association between hsCRP and lean appendicular mass 
was demonstrated in a large cohort study [33]. Baseline 
DHEA-S levels correlated with change in gait speed; age-
related reduced DHEA-S has been shown to correlate 
with reduced physical performance [34]. We will further 
evaluate this in our larger study; a proven association 
may suggest exogenous DHEA-S could be used to protect 
older adults from acute declines in physical performance.
Our main study will fully characterise acute muscle 
changes, and acute sarcopenia in elective and emergency 
patients. This will include CGA, particularly nutritional 
and physical function assessment, and measurement of 
biomarkers of immune-endocrine function, as guided by 
our pilot results. Follow-up will be conducted to assess if 
acute changes in muscle mass and function are predictive 
of change in physical function at 3 months.
Limitations
Firstly, we recognise that, although tests of statistical sig-
nificance were performed, this pilot study was not pow-
ered to identify changes in muscle mass or function. We 
fully acknowledge that no definite conclusions can be 
made from this study alone. However, we consider these 
results may be of value in future research and, potentially, 
used in a systematic review. Our results have reaffirmed 
the need for our larger study, and assisted with power 
calculations.
An important characteristic that differed from expected 
population within this study was gender. Percentage of 
elective colorectal surgery procedures performed on 
females has been reported as 41.7–56.2% [35–37]. This 
is important as muscle echotexture, muscle: SC tissue 
Fig. 2 Association of DHEA‑S to change in gait speed and hsCRP to change in BATT. There was a positive association between baseline DHEA‑S and 
change in gait speed (τb = 0.87, p = 0.02) (a) and a positive association between baseline hsCRP and change in BATT (τb = 0.73, p = 0.04) (b)
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ratio, and muscle force generation and relaxation are 
reported to differ between genders [38]. We acknowledge 
that analysis of genders together may have confounded 
results.
All assessments were performed by a single investi-
gator. Although this ensured standardisation of tech-
nique, this may have induced systematic error. Handgrip 
strength is recommended to be measured with the partic-
ipant sat upright and elbow flexed at 90°. Measurements 
were taken in this position wherever the participant was 
able to sit out; however, in some circumstances at Visit 2 
this was not possible. In these cases, handgrip strength 
was assessed with the participant in a semi-upright posi-
tion in bed with elbow flexed as close to 90° as possible. 
This may have affected results at this time point.
Lastly, there is some evidence that position of the par-
ticipant when measuring quadriceps thickness can affect 
results [39]. Measurement has been recommended with 
the participant lying supine, as most objectively stand-
ardised position [40]. However, some participants were 
unable to lie flat at Visit 2, due to increased intraabdomi-
nal strain and postoperative nausea. Therefore, ultra-
sound assessments were performed in a semi-upright 
position. An attempt was made to standardise this 
position as much as possible, but this was not assessed 
objectively; there may have been some variability in bed 
position between visits. Measurements taken in the refer-
ence population were taken in a similar position [10].
Additional file
Additional file 1. Recruitment and follow‑up flowchart. Flowchart to 
clearly demonstrate recruitment, enrolment, and follow‑up of participants 
within this research study.
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